← Evidence map

ArticleDrug design, development and therapy2023

The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives.

Sarfaraz K NiaziPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37701048